PAM
TRAW icon

Panagora Asset Management’s Traws Pharma TRAW Stock Holding History

Panagora Asset Management’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-18
Closed -$49K – 2535
2018
Q3 		$49K Buy
18
+16
+800% +$40.8K ﹤0.01% 2024
2018
Q2 		$5K Sell
2
-5
-71% -$14.5K ﹤0.01% 2310
2018
Q1 		$33K Buy
7
+1
+17% +$7.14K ﹤0.01% 2136
2017
Q4 		$53K Sell
6
-1
-14% -$10.3K ﹤0.01% 2040
2017
Q3 		$67K Buy
7
+3
+75% +$31K ﹤0.01% 1996
2017
Q2 		$53K Buy
4
+2
+100% +$24.8K ﹤0.01% 2057
2017
Q1 		$26K Buy
+2
New +$31K ﹤0.01% 2120

Other funds holding TRAW

6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
TCP
Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Panagora Asset Management's TRAW Position: Q4 2018 in Review

Panagora Asset Management sold out of Traws Pharma (TRAW) in Q4 2018, closing a stake of 18 shares — an estimated $49K sold.

Panagora Asset Management first reported a position in TRAW in Q1 2017 and held it in 7 quarters. The position peaked at $67K in Q3 2017. 16 funds tracked by Wall St. Rank hold TRAW as of Q4 2018.

  • Panagora Asset Management reported no remaining Traws Pharma position as of Q4 2018 after selling out during the quarter.
  • Panagora Asset Management sold 18 Traws Pharma shares in Q4 2018, an estimated $49K.
  • Panagora Asset Management first reported a position in Traws Pharma in Q1 2017 and held it in 7 quarters.
  • Panagora Asset Management's Traws Pharma position peaked at $67K in Q3 2017.
  • 16 funds tracked by Wall St. Rank held Traws Pharma as of Q4 2018.

Based on Panagora Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.